343 related articles for article (PubMed ID: 28405764)
21. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A
Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668
[TBL] [Abstract][Full Text] [Related]
22. Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.
Narayanan S; Kawaguchi T; Peng X; Qi Q; Liu S; Yan L; Takabe K
Sci Rep; 2019 Sep; 9(1):13455. PubMed ID: 31530839
[TBL] [Abstract][Full Text] [Related]
23. PD-L1 Expression in colorectal carcinoma and its correlation with clinicopathological parameters, microsatellite instability and BRAF mutation.
Srivastava P; Husain N; Shukla S; Chauhan S; Pandey A; Masood S
Indian J Pathol Microbiol; 2021; 64(3):490-496. PubMed ID: 34341259
[TBL] [Abstract][Full Text] [Related]
24. Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer.
Xiao X; Dong D; He W; Song L; Wang Q; Yue J; Xie L
Gynecol Oncol; 2018 Apr; 149(1):146-154. PubMed ID: 29496294
[TBL] [Abstract][Full Text] [Related]
25. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.
Kim JH; Kang GH
World J Gastroenterol; 2014 Apr; 20(15):4230-43. PubMed ID: 24764661
[TBL] [Abstract][Full Text] [Related]
26. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.
Walsh MD; Dent OF; Young JP; Wright CM; Barker MA; Leggett BA; Bokey L; Chapuis PH; Jass JR; Macdonald GA
Int J Cancer; 2009 Sep; 125(5):1231-7. PubMed ID: 19462453
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer.
Morihiro T; Kuroda S; Kanaya N; Kakiuchi Y; Kubota T; Aoyama K; Tanaka T; Kikuchi S; Nagasaka T; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
Sci Rep; 2019 Mar; 9(1):4633. PubMed ID: 30874607
[TBL] [Abstract][Full Text] [Related]
28. The effects of ARID1A mutations on colorectal cancer and associations with PD-L1 expression by stromal cells.
Kamori T; Oki E; Shimada Y; Hu Q; Hisamatsu Y; Ando K; Shimokawa M; Wakai T; Oda Y; Mori M
Cancer Rep (Hoboken); 2022 Jan; 5(1):e1420. PubMed ID: 34042312
[TBL] [Abstract][Full Text] [Related]
29. The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
Marisa L; Svrcek M; Collura A; Becht E; Cervera P; Wanherdrick K; Buhard O; Goloudina A; Jonchère V; Selves J; Milano G; Guenot D; Cohen R; Colas C; Laurent-Puig P; Olschwang S; Lefèvre JH; Parc Y; Boige V; Lepage C; André T; Fléjou JF; Dérangère V; Ghiringhelli F; de Reynies A; Duval A
J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922790
[TBL] [Abstract][Full Text] [Related]
30. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
[TBL] [Abstract][Full Text] [Related]
31. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
32. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
33. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis.
Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
35. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.
Buckowitz A; Knaebel HP; Benner A; Bläker H; Gebert J; Kienle P; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2005 May; 92(9):1746-53. PubMed ID: 15856045
[TBL] [Abstract][Full Text] [Related]
36. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
[TBL] [Abstract][Full Text] [Related]
37. T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.
Bauer K; Nelius N; Reuschenbach M; Koch M; Weitz J; Steinert G; Kopitz J; Beckhove P; Tariverdian M; von Knebel Doeberitz M; Kloor M
Cancer Immunol Immunother; 2013 Jan; 62(1):27-37. PubMed ID: 22729559
[TBL] [Abstract][Full Text] [Related]
38. High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.
Pfuderer PL; Ballhausen A; Seidler F; Stark HJ; Grabe N; Frayling IM; Ager A; von Knebel Doeberitz M; Kloor M; Ahadova A
Br J Cancer; 2019 Aug; 121(5):395-404. PubMed ID: 31358939
[TBL] [Abstract][Full Text] [Related]
39. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression.
Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
